The Antiviral Effect of Soyasaponin‐II Against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/1523780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 18.11.2026. Verfasst von Kexin Gao und 14 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to the global swine industry. Currently, there are limited effective antiviral interventions available for PRRSV‐infected farms, underscoring the urgent need for novel antiviral strategies. This study evaluates the antiviral efficacy of soyasaponin‐II (SS‐II) against PRRSV both in vitro and in vivo. The results showed that SS‐II significantly inhibits PRRSV replication in Marc‐145 cells and primary porcine alveolar macrophages (PAMs). In vivo, the SS‐II treatment group exhibited marked alleviation of clinical symptoms and pathological lesions associated with PRRSV infection. Complete blood count (CBC) analysis revealed that oral administration of SS‐II did not significantly alter white blood cell (WBC) or platelet (PLT) counts, nor did it induce additional hematological toxicity. Subsequently, time‐of‐addition and viral life cycle assays indicated that SS‐II exerted its inhibitory effects primarily at the stages of viral RNA transcription and replication, rather than at the earlier stages of viral binding, internalization, and membrane fusion. The direct interaction between SS‐II and 3CLpro was confirmed by biolayer interferometry (BLI) and fluorescence resonance energy transfer (FRET) assays, which demonstrated that 3CLpro is a promising candidate target of SS‐II. Taken together, these findings indicate that SS‐II holds promise as a potential antiviral agent and represents a viable strategy for combating PRRSV infection.
Förderung
- Natural Science Foundation of Heilongjiang Province
- National Natural Science Foundation of China
Zitieren
APA
Gao, K., Tang, Y., Pan, S., Zhang, Y., Bai, Y., Su, S., Zhou, B., Shi, X., Wang, H., Yu, C., Yang, Y., An, T., Li, Y., Cai, X., & Wang, S. (2026). The Antiviral Effect of Soyasaponin‐II Against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/1523780
Vancouver
Gao K, Tang Y, Pan S, Zhang Y, Bai Y, Su S, et al. The Antiviral Effect of Soyasaponin‐II Against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/1523780
BibTeX
@article{Gao2026,
author = {Gao, Kexin and Tang, Yan-Dong and Pan, Siyu and Zhang, Yanhe and Bai, Yuanzhe and Su, Shibo and Zhou, Bingqian and Shi, Xinqi and Wang, Haiwei and Yu, Changqing and Yang, Yong-Bo and An, Tong-Qing and Li, Yanhua and Cai, Xuehui and Wang, Shujie},
title = {The Antiviral Effect of Soyasaponin‐II Against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/1523780}
}
EUVIMED